Does systemic inflammation and immune activation contribute to fracture risk in HIV?

July 31, 2016 at 9:30 pm

Current Opinion In HIV and AIDS May 2016 V.11 N.3 P.253–260

McGinty, Tara; Mirmonsef, Paria; Mallon, Patrick W.G.

aHIV Molecular Research Group, School of Medicine, University College Dublin

bDepartment of Infectious Diseases, Mater Misericordiae University Hospital, Dublin, Ireland

cDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, Illinois, USA

*Tara McGinty and Paria Mirmonsef have contributed equally to the writing of this article.

Purpose of review

There is increasing evidence pointing toward an important role of heightened immune activation and inflammation in people living with HIV contributing to the development of non-AIDS comorbidities. This review aims to explore low bone mineral density (BMD) in HIV with a focus on the underlying mechanisms and relationships between the immune and skeletal systems.

Recent findings

Baseline immune activation and inflammation negatively impact BMD at antiretroviral therapy (ART) initiation. B- and T-cell alterations in HIV lead to an imbalance in the osteoblastic osteoprotegerin (OPG) and osteoclastic receptor activator of NF-κB ligand (RANKL) cytokines which favours osteoclastogenesis and bone resorption. These findings suggest an important role for immune-mediated mechanisms in the pathogenesis of low BMD in HIV.

Summary

Bone homeostasis is in part regulated by cells of the immune system through complex interactions with the RANK/RANKL/OPG Disturbances in the normal functioning of T, B cells, and monocytes in HIV and the resulting proinflammatory state may contribute to dysregulation of this finely controlled balance leading to increased bone loss. Pre-ART levels of immune activation and inflammation have a consistently negative effect on BMD and further suggest the immunocentric basis of bone loss in HIV alongside supporting the benefits of earlier ART initiation. Further longitudinal studies will help determine the effect this will have on fracture risk in people living with HIV.

FULL TEXT

http://journals.lww.com/co-hivandaids/Fulltext/2016/05000/Does_systemic_inflammation_and_immune_activation.3.aspx

PDF (CLIC in PDF

 

Entry filed under: Antirretrovirales, HIV/SIDA, HIV/SIDA HAART, HIV/SIDA Trastornos Oseos, Infecciones virales, Metodos diagnosticos, Update. Tags: .

Working towards an understanding of bone disease in HIV How to predict the risk of fracture in HIV?


Calendar

July 2016
M T W T F S S
« Jun   Aug »
 123
45678910
11121314151617
18192021222324
25262728293031

Most Recent Posts


%d bloggers like this: